Delhi High Court · 2025-11-17
FMC CORPORATION & ORS. vs NATCO PHARMA LIMITED
- Citation / case number
- CS(COMM)-607/2024 2025:DHC:10092
- Court
- Delhi High Court
- Petitioner
- FMC CORPORATION & ORS.
- Respondent
- NATCO PHARMA LIMITED
Judgment text excerpt
$~ * IN THE HIGH COURT OF DELHI AT NEW DELHI CS(COMM) 607/2024 & I.A. 34151/2024 FMC CORPORATION & ORS. .....Plaintiffs Through: Mr. Sandeep Sethi, Mr. Adarsh Ramanujan, Ms. Bitika Sharma, Ms. Aadya Chawla, Mr. George Vithayathil, Ms. S. L. Soujanya Ms. Ahaana Singh Rana, Ms. Mrinalini Goyat and Mr. Parth Singh, Advs. Mob: 8449336373 Email: [email protected] versus NATCO PHARMA LIMITED .....Defendant Through: Mr. J. Sai Deepak, Sr. Adv. with Mr. Sidhant Goel, Mr. Mohit Goel, Mr. Aditya Goel, Mr. Deepankar Mishra, Mr. Kartikeya Tandon and Mr. Avinash K. Sharma, Advs. Mob: 9716746496 Email: [email protected] CORAM: HON'BLE MS. JUSTICE MINI PUSHKARNA JUDGEMENT % 17.11.2025 I.A. 34151/2024 in CS(COMM) 607/2024 INTRODUCTION 1. By way of the present judgement, this Court shall decide the application being I.A. 34151/2024, filed by the plaintiffs under Order XXXIX Rules 1 & 2 read with Section 151 of the Civil Procedure Code, 1908 (“CPC”), seeking an interim injunction for restraining the infringement of the plaintiffs‟ patented Compound of Formula 3 as claimed in Claim 12 of the Indian Patent No. 298645 (“IN’645 / suit patent”), titled as “Method For Preparing N- Signature Not CS(COMM) Verified 607/2024 Page 1 of 79 Digitally Signed By:HARIOM SHARMA Signing Date:17.11.2025 15:20:13 Phenylpyrazole-1-Carboxamides”. 2. The suit has been filed by the plaintiffs as a quia timet action under Section 48 read with Section 108 of the Patents Act, 1970 (“the Act”), seeking permanent injunction, restraining the defendant from manufacturing/preparing the product, „Cyantraniliprole 10.26% OD (Oil Dispersion)‟ (“infringing/impugned product”) and/or other admixture, combination, formulation products containing Cyantraniliprole using the Compound of Formula 3 as claimed in Claim